Uncategorized

ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration

by Business Wire • 2017/02/07 • 0 Comments

ST. MARYS, W. Va.--(BUSINESS WIRE)--ProtoKinetix Updates Testing Progress on Neuronal Retinal Cells in Living Tissue for the Treatment of Macular Degeneration

Full Story →

← Stentrode Minimally Invasive Brain-Machine Interface: Interview with Dr. Thomas Oxley, Neurologist at Royal Melbourne Hospital

Good manufacturing pathway needed for FDA to consider new drug approvals →

Post navigation